Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Virginia Kaklamani
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Virginia Kaklamani
453 views
September 23, 2024
Chapters
KEYNOTE-522: Immunotherapy in Early-Stage TNBC
00:00
Adjuvant Endocrine Therapy Advances
02:45
DESTINY-BREAST12: HER2-Low Breast Cancer Treatment
04:20
CAPItello-290: AKT Pathway Targeting
06:49
Login to view comments.
Click here to Login